Narrow Your Search

Narrow Your Search

Focus

Publisher

Companies

People

Articles

6,929 Articles
Psychedelic Invest
Psychedelic Invest
/
Jun 14, 2024

Largest Study of Psychedelic Medicine, with 11,441 Mindbloom Clients, Demonstrates Effectiveness and Safety of Guided At-Home Ketamine Therapy

AUSTIN, Texas, June 14, 2024 /PRNewswire/ — Mindbloom, the leading provider of psychedelic therapy, announced today the findings of the largest peer-reviewed study in the history of ketamine therapy and psychedelic medicine. The study was published in the Journal of Affective Disorders, and...
Ketamine
Psilocybin Alpha
Psilocybin Alpha
/
Jun 14, 2024

Pα+ Psychedelic Bulletin #164: Lykos Dominates News Cycle; EPIsoDE Trial Readout; EU Drug Report Discusses Psychedelics; DEA Should Improve RFRA Petition Process; Other News

Gosh, it’s been a busy few weeks! Our news cycle has been dominated by Lykos Therapeutics-related stories, from ICER’s report and panel meeting through to FDA’s Advisory Committee meeting and yesterday’s patent-related news. Elsewhere in the psychedelics field, things have been a little...
DoubleBlind Mag
DoubleBlind Mag
/
Jun 14, 2024

14 of the Very Best Mushroom Memes

Mushrooms have a good sense of humor. They not only make you see the absurdity of our everyday reality but can also bring out your playful inner child. While shroom trips can be dark, they can also be full of giggle fits—and there are many laughs to be had about mushrooms, even while sober. Not...
DoubleBlind Mag
DoubleBlind Mag
/
Jun 14, 2024

Psychedelic Visuals Are Produced in the Backs of Our Eyeballs, New Theory Suggests

The psychedelic experience amounts to a mesmerizing, stupefying, and at times terrifying, divine ride into the cosmos and back. Naturally, the specifics vary wildly, depending on set, setting, and the psychedelic itself – plus the quantity consumed. But when it comes to visual hallucinations,...
DMT
Psychedelic Invest
Psychedelic Invest
/
Jun 14, 2024

UC Berkeley’s Groundbreaking Study Exploring Psilocybin’s Effects on Perception

The UC Berkeley Center for the Science of Psychedelics has embarked on an unprecedented study to explore why psilocybin, a psychoactive compound found in certain mushrooms, alters visual perception in humans. This investigation represents the university’s first human trials involving a Schedule I...
Psilocybin Psychedelics
Psychedelic Invest
Psychedelic Invest
/
Jun 14, 2024

Lykos Therapeutics Addresses Concerns Over MDMA Treatment for PTSD

A week after an FDA committee voted against recommending midomafetamine (MDMA) treatment for post-traumatic stress disorder (PTSD), Lykos Therapeutics is working to clarify the situation and address concerns that have emerged in the broader conversation. This effort comes in the wake of significant...
MDMA
Psychedelic Invest
Psychedelic Invest
/
Jun 14, 2024

Psychedelic Retreats Market Set to Cross $1 Trillion By 2027

The market for psychedelic retreats is on a remarkable trajectory, with projections indicating it will surpass the $1 trillion mark by 2027. This anticipated milestone reflects the rapid expansion and increasing acceptance of psychedelic therapy as an effective treatment for various mental health...
MDMA
DoubleBlind Mag
DoubleBlind Mag
/
Jun 13, 2024

Growing Magic Truffles: A Beginner’s Guide 

Though many in the psychedelic community know them as “magic truffles,” the dense nuggets often sold in places like the Netherlands are technically sclerotia. Truffles, like the edible kinds rummaged up by trained dogs or pigs and grated over your pasta, contain fungus spores and are actually a...
Psilocybin
Psychedelic Invest
Psychedelic Invest
/
Jun 13, 2024

Filament Health Announces Closing of Warrant Exercise, Note Conversion and Concurrent Private Placement of Common Shares

VANCOUVER, BC, June 12, 2024 /CNW/ – Filament Health Corp. (OTCQB: FLHLF) (Cboe CA: FH) (FSE: 7QS) (“Filament” or the “Company“), a clinical‐stage natural psychedelic drug development company, today announces that, further to its press release dated June 3, 2024, it has completed...
Psychedelic Invest
Psychedelic Invest
/
Jun 13, 2024

Psyched Wellness Developing Amanita Muscaria Gummies for Sale in the USA

Toronto, Ontario–(Newsfile Corp. – June 13, 2024) – Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the “Company” or “Psyched“), a life sciences company focused on the production and distribution of health and wellness products derived from the Amanita Muscaria mushroom,...
DoubleBlind Mag
DoubleBlind Mag
/
Jun 13, 2024

California Will Not Legalize Widespread Access to Psychedelic Therapy Any Time Soon

Psychedelic therapy will remain underground—and technically illegal—for the foreseeable future in California. Senate Bill 1012, introduced by Senator Scott Wiener, aimed to mainstream psychedelics by legalizing their use in therapy across California. However, the bill hit a roadblock in mid-May...
Ketamine
Psychedelic Invest
Psychedelic Invest
/
Jun 12, 2024

Revive Therapeutics Provides Update on FDA Type C Meeting for Clinical Study of Bucillamine to Treat Long COVID

TORONTO, June 12, 2024 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and development of therapeutics and diagnostics for infectious diseases, medical...
Psychedelics Today
Psychedelics Today
/
Jun 12, 2024

Why Are Some Parents Choosing Psychedelics Over SSRIs for Teens?

Disclaimer: The content of this article does not constitute medical advice. At the time of this writing, psychedelics remain largely illegal in the United States. We urge parents to consult with doctors and legal experts before considering psychedelic therapy for their children. *All names and...
Psychedelics
Lucid News
Lucid News
/
Jun 12, 2024

Tram Day Celebrates Female LSD Pioneer Susi Ramstein

The Women’s Visionary Council (WVC) is joining with The Alembic, a consciousness education center in Berkeley, CA, to inaugurate an annual celebration of Susi Ramstein, the first LSD guide and the first woman to take LSD. The WVC and the Alembic will host a special presentation tonight, June 12,...
LSD
DoubleBlind Mag
DoubleBlind Mag
/
Jun 12, 2024

Congress Officially Supports Psychedelics More Than Cannabis, VA Official Says

A top official with the U.S. Department of Veterans Affairs (VA) says there’s an “unstoppable narrative” in support of advancing psychedelic medicine, with a combination of compelling personal stories of recovery and robust clinical data from studies he’s hoping to expand upon. He also said...
Psychedelics
Psychedelics - Green Market Report
Psychedelics - Green Market Report
/
Jun 12, 2024

Atai bids to buy IntelGenx

IntelGenx Corp. (OTCQB: IGXT) (TSX: IGX) was granted protection under the Companies Creditors Arrangement Act, which is the Canadian version of bankruptcy. The company told investors that on May 27, the court granted an order that approved a sale and investment solicitation process for its assets....
Psychedelic Invest
Psychedelic Invest
/
Jun 12, 2024

Mindbio Therapeutics Reports Secondary Data: Improvement of Psychological Outcomes & Safety Results in Depressed Patients from Phase 2A Depression Trial

MindBio Therapeutics Corp. reported positive secondary data from its world-first take-home microdosing depression trial using MB22001 completed earlier this year. Data from MindBio’s Phase 2A Depression trial indicates improvements in a range of secondary outcome measures following an 8-week...
Psychedelic Invest
Psychedelic Invest
/
Jun 11, 2024

Optimi Health Completes First International Shipment of MDMA to Israel and Secures CBSA Exporters Authorization ID

Vancouver, British Columbia–(Newsfile Corp. – June 11, 2024) – Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) (“Optimi” or the “Company“), a leading Health Canada licensed GMP psychedelics pharmaceutical manufacturer, specializing in controlled substances such as botanical...
Psilocybin MDMA
DoubleBlind Mag
DoubleBlind Mag
/
Jun 11, 2024

Psilocybin Mushroom Potency Can Degrade by Nearly 50% in Six Months, New Data Shows

We’ve all been there. You acquire some mushrooms, eat a few handfuls, and store the rest in a baggie or container in the back of your closet. Next thing you know, six months go by, and you remember the pot of gold you have sitting in the shoe box next to a storage bin of junk you never unpacked...
Psilocybin
DoubleBlind Mag
DoubleBlind Mag
/
Jun 11, 2024

An Enthusiast’s Guide to Psilocybe natalensis

Psilocybe cubensis is the best-known psilocybin mushroom, holding center stage in cultivator circles due to its wide distribution and the ease of its cultivation. The span of influence woven by its wide mycelial web has been deep and far-reaching, but its place at the top may not last forever: A...
Psilocybin
Psychedelics Today
Psychedelics Today
/
Jun 11, 2024

From the Eleusinian Mysteries to Modern Mysticism: The Role of Religion in the Psychedelic Experience

In this episode, Joe interviews Charles Stang: Professor of Early Christian Thought and the Director of the Center for the Study of World Religions at Harvard Divinity School. The Center was created to gain a better understanding of world religions by bringing scholars from their respective...
Psilocybin Alpha
Psilocybin Alpha
/
Jun 11, 2024

Natural Medicine Advisory Bulletin 11.5: Rule Review & Roadmap

Written by the Vicente LLP team as part of our Colorado Natural Medicine Health Act Tracker. In this Issue Add a header to begin generating the table of… Source
DoubleBlind Mag
DoubleBlind Mag
/
Jun 11, 2024

The Playful History of Tarot

These days, it’s rare to come across someone who hasn’t heard of tarot:  In one 2021 survey, half of Americans ages 13 to 25 said they used tarot cards or some other form of fortunetelling, and the market for tarot cards is predicted to grow by over $200 million from 2021-2026. But a few...
Psychedelic Invest
Psychedelic Invest
/
Jun 11, 2024

Clearmind Medicine Revolutionizes the $13 Billion NonAlcoholic Beverages Market with its Psychedelic-Based Drink

Vancouver, Canada, June 11, 2024 (GLOBE NEWSWIRE) —  Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the “Company”), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated health...
Psychedelics - Green Market Report
Psychedelics - Green Market Report
/
Jun 11, 2024

Numinus walks back claims made in press releases

Nearly two months after sending out press releases that crowed about the company’s advancements, Numinus Wellness Inc. (OTC: NUMIF) walked back those claims and blamed its public relations firm for the mistake. Numinus released a statement after the markets closed on Friday, June 7, saying,...
MDMA
Psychedelic Invest
Psychedelic Invest
/
Jun 11, 2024

Cybin Appoints Dr. Atul Mahableshwarkar M.D., as Senior Vice President, Clinical Development

Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) (“Cybin” or the “Company”), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative next-generation psychedelic-based treatment options, is pleased to announce that Dr. Atul R....
DMT
Psychedelics - Green Market Report
Psychedelics - Green Market Report
/
Jun 11, 2024

Appeals court to hear case on psilocybin use by terminally ill

The Ninth Circuit Court of Appeals is set to hear arguments in August in a closely watched case about whether terminally ill patients have the right to use the psychedelic drug psilocybin under federal and state “right-to-try” laws, Law360 reported. The case, Advanced Integrative Medical...
Psychedelic Invest
Psychedelic Invest
/
Jun 11, 2024

Revive Therapeutics Provides Update From FDA Meeting for Long COVID Diagnostic Product

TORONTO, June 10, 2024 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and development of therapeutics and diagnostics for infectious diseases, medical...
Psychedelics - Green Market Report
Psychedelics - Green Market Report
/
Jun 10, 2024

FDA issues warning for mushroom chocolate bars linked to illnesses

The U.S. Food and Drug Administration warned consumers that certain mushroom-containing chocolate bars have been linked to illnesses in eight people across four states. In an alert issued Friday, the FDA said it received reports of adverse reactions, including seizures, loss of consciousness, and...
Psychedelic Invest
Psychedelic Invest
/
Jun 10, 2024

Psychedelics Companies Reeling After FDA Vote

Here’s what investors need to know. Shares of prominent psychedelics companies, including Compass Pathways, Atai Life Sciences, and Mind Medicine, experienced a significant decline following an unexpected vote by the Food and Drug Administration (FDA) on June 4. Notably, none of these companies...
MDMA Psychedelics
DoubleBlind Mag
DoubleBlind Mag
/
Jun 10, 2024

The Best Books About Growing Psychedelic Mushrooms

Magic mushrooms are incredibly diverse in nature and pop up across large areas of the world when they’re in season. But there is a looming uncertainty around whether natural supplies can meet the soaring (ahem, mushrooming) demand for psilocybin-fueled inner growth and play.  To aid in the...
Psilocybin
Microdose
Microdose
/
Jun 10, 2024

Revitalist and Wake Network Launch Psychedelic Retreats for Practitioners and Clients Providing Immersive Therapies and Trainings

Revitalist and Wake Network Partner to Offer Clinical Psychedelic Retreats in the British Virgin Islands Revitalist Lifestyle and Wellness Ltd. (CSE: CALM) (OTCQB: RVLWF) (FSE: 4DO), a leader in mental health and wellness, has announced a significant partnership with Wake Network, Inc., a pioneer in...
Psychedelic Invest
Psychedelic Invest
/
Jun 07, 2024

Red Light Holland Announces Completion of Full Psilocybin Extraction Report with PharmAla

Toronto, Ontario–(Newsfile Corp. – June 7, 2024) – Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) (“Red Light Holland”), a company engaged in the production, growth, and sale of functional mushrooms and mushroom home grow kits in North America and Europe, as well as a...
Psilocybin
Psychedelic Invest
Psychedelic Invest
/
Jun 07, 2024

Numinus Wellness Comments on FDA Advisory Committee Meeting for Investigational MDMA-Assisted Therapy for PTSD

VANCOUVER, BC, June 7, 2024 /CNW/ – Numinus Wellness Inc. (“Numinus” or the “Company”) (TSX: NUMI) (OTCQX: NUMIF), a leader in mental health care specializing in innovative and evidence-based treatments, comments on the results of June 4, 2024 meeting of the U.S. Food and Drug...
MDMA
Psychedelic Invest
Psychedelic Invest
/
Jun 07, 2024

Silo Pharma Announces Successful Production of its SP-26 Ketamine Implant for Fibromyalgia

SARASOTA, FL, June 07, 2024 (GLOBE NEWSWIRE) — Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on developing novel formulations and drug delivery systems for traditional therapeutics and psychedelic treatments, today...
Ketamine
Psychedelic Invest
Psychedelic Invest
/
Jun 07, 2024

Effective Psychedelic Treatment for Long-COVID Symptoms: A Case Study

Long-COVID, also known as post-acute sequelae of SARS-CoV-2 infection, encompasses a range of symptoms that persist even after an individual has seemingly recovered from COVID-19. These symptoms can include cognitive impairment, fatigue, depression, anxiety, headaches, and joint pain. Currently,...
Psilocybin MDMA Psychedelics